Skip to Content
Merck

Noncoding RNA MaIL1 is an integral component of the TLR4-TRIF pathway.

Proceedings of the National Academy of Sciences of the United States of America (2020-04-04)
Marina Aznaourova, Harshavardhan Janga, Stephanie Sefried, Andreas Kaufmann, Jens Dorna, Sarah M Volkers, Philipp Georg, Marcus Lechner, Judith Hoppe, Simon Dökel, Nils Schmerer, Achim D Gruber, Uwe Linne, Stefan Bauer, Leif E Sander, Bernd Schmeck, Leon N Schulte
ABSTRACT

RNA has been proposed as an important scaffolding factor in the nucleus, aiding protein complex assembly in the dense intracellular milieu. Architectural contributions of RNA to cytosolic signaling pathways, however, remain largely unknown. Here, we devised a multidimensional gradient approach, which systematically locates RNA components within cellular protein networks. Among a subset of noncoding RNAs (ncRNAs) cosedimenting with the ubiquitin-proteasome system, our approach unveiled ncRNA MaIL1 as a critical structural component of the Toll-like receptor 4 (TLR4) immune signal transduction pathway. RNA affinity antisense purification-mass spectrometry (RAP-MS) revealed MaIL1 binding to optineurin (OPTN), a ubiquitin-adapter platforming TBK1 kinase. MaIL1 binding stabilized OPTN, and consequently, loss of MaIL1 blunted OPTN aggregation, TBK1-dependent IRF3 phosphorylation, and type I interferon (IFN) gene transcription downstream of TLR4. MaIL1 expression was elevated in patients with active pulmonary infection and was highly correlated with IFN levels in bronchoalveolar lavage fluid. Our study uncovers MaIL1 as an integral RNA component of the TLR4-TRIF pathway and predicts further RNAs to be required for assembly and progression of cytosolic signaling networks in mammalian cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
o-Phenylenediamine dihydrochloride, tablet, 20 mg substrate per tablet
Amersham Protran® Premium Western blotting membranes, nitrocellulose, pore size 0.45 μm, roll W × L 300 mm × 4 m, pkg of 1 ea